Reports of Biochemistry
and Molecular Biology
Sat, Dec 21, 2024
[Archive]
Volume 11, Issue 1 (Vol.11 No.1 Apr 2022)
rbmb.net 2022, 11(1): 166-175 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Muhammed Ali R A, Ridha Alshara J M, Saaid Tuwaij N S, Baker Al-khilkhali H J. Study of Antibacterial Chemical Substances and Molecular Investigation among Sulfamethoxazole-trimethoprim (SXT)- Resistant Escherichia coli Isolates. rbmb.net 2022; 11 (1) :166-175
URL: http://rbmb.net/article-1-893-en.html
URL: http://rbmb.net/article-1-893-en.html
Ruaa Ali Muhammed Ali 
, Jamal Mohammed Ridha Alshara , Nabil Salim Saaid Tuwaij * , Huda Jameel Baker Al-khilkhali
, Jamal Mohammed Ridha Alshara , Nabil Salim Saaid Tuwaij * , Huda Jameel Baker Al-khilkhali
Faculty of Science, University of Kufa, Kufa, Iraq.
Abstract: (2215 Views)
Background: Escherichia coli (E. coli) remains one of the leading agents of urinary tract infection (UTIs), it has become resistant to many drugs. Current work aimed to evaluate some chemical substances as antibacterial agents and molecular study of virulence factors associated with UTIs.
Methods: This work involved 133 urine specimens obtained from females’ patients suffering from UTIs, Methods of well diffusion and disk diffusion were achieved to assay the effect of some chemical substances and antibiogram profiles toward Sulfamethoxazole-trimethoprim (SXT)-resistant E. coli respectively. Virulence genes were done based on the technique of Polymerase Chain Reaction (PCR).
Results: The results recorded 49/133 (36.84%) E. coli among women suffering UTIs, 28/49 (57.14%) were resistant to SXT drug. imipenem, meropenem, and nitrofurantoin were recorded more effectively. Chemicals substances at the concentration 0.3 (g/ml) recorded percentages of inhibition, reaching 9.143±1.442, 15.36±0.5914, and 21.82±0.8699 for NaHCO3, Ch4c, and Viroxide Super™ respectively. PCR demonstrated that 28/28 (100%) of SXT-resistant E. coli isolates were harbored Sul-2, FeoB and PapC genes, while 14/28 (50%), 15/28 (53.57%), 19/28 (67.85%) and 26/28 (92.85%) in U250 (pet), FumC, Sul-1 and IutA genes, respectively. Sul-3 gene was not observed.
Conclusions: Observed a high percentage of E. coli that were resistant to SXT drug, and having several virulence genes, poses a real threat, it requires a real pause to create substitutions to limit the spreading of this threat.
Methods: This work involved 133 urine specimens obtained from females’ patients suffering from UTIs, Methods of well diffusion and disk diffusion were achieved to assay the effect of some chemical substances and antibiogram profiles toward Sulfamethoxazole-trimethoprim (SXT)-resistant E. coli respectively. Virulence genes were done based on the technique of Polymerase Chain Reaction (PCR).
Results: The results recorded 49/133 (36.84%) E. coli among women suffering UTIs, 28/49 (57.14%) were resistant to SXT drug. imipenem, meropenem, and nitrofurantoin were recorded more effectively. Chemicals substances at the concentration 0.3 (g/ml) recorded percentages of inhibition, reaching 9.143±1.442, 15.36±0.5914, and 21.82±0.8699 for NaHCO3, Ch4c, and Viroxide Super™ respectively. PCR demonstrated that 28/28 (100%) of SXT-resistant E. coli isolates were harbored Sul-2, FeoB and PapC genes, while 14/28 (50%), 15/28 (53.57%), 19/28 (67.85%) and 26/28 (92.85%) in U250 (pet), FumC, Sul-1 and IutA genes, respectively. Sul-3 gene was not observed.
Conclusions: Observed a high percentage of E. coli that were resistant to SXT drug, and having several virulence genes, poses a real threat, it requires a real pause to create substitutions to limit the spreading of this threat.
Type of Article: Original Article |
Subject:
Microbiology
Received: 2022/03/22 | Accepted: 2022/03/23 | Published: 2022/05/26
Received: 2022/03/22 | Accepted: 2022/03/23 | Published: 2022/05/26
References
1. Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019;11:3-7. [DOI:10.1177/1756287219832172] [PMID] [PMCID]
2. Odoki M, Almustapha Aliero A, Tibyangye J, Nyabayo Maniga J, Wampande E, Drago Kato C, et al. Prevalence of bacterial urinary tract infections and associated factors among patients attending hospitals in Bushenyi district, Uganda. International journal of microbiology. 2019;1-8. [DOI:10.1155/2019/4246780] [PMID] [PMCID]
3. Bartoletti R, Cai T, Wagenlehner FM, Naber K, Bjerklund Johansen TE. Treatment of urinary tract infections and antibiotic stewardship. Eur Urol Suppl. 2016;15(4):81-87. [DOI:10.1016/j.eursup.2016.04.003]
4. Bischoff S, Walter T, Gerigk M, Ebert M, Vogelmann R. Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department. BMC Infect Dis. 2018;18(1):56. [DOI:10.1186/s12879-018-2960-9] [PMID] [PMCID]
5. Kot B. Antibiotic resistance among uropathogenic Escherichia coli. Pol J Microbiol. 2019;68(4):403-415. [DOI:10.33073/pjm-2019-048] [PMID] [PMCID]
6. Pakbin B, Brück WM, Rossen JW. Virulence factors of enteric pathogenic Escherichia coli: A review. Int J Mol Sci. 2021;22(18):9922. [DOI:10.3390/ijms22189922] [PMID] [PMCID]
7. Sarowska J, Futoma-Koloch B, Jama-Kmiecik A, Frej-Madrzak M, Ksiazczyk M, Bugla-Ploskonska G, et al. Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: recent reports. Gut pathogens. 2019;11:1-6. [DOI:10.1186/s13099-019-0290-0] [PMID] [PMCID]
8. Collee J G, Fraser AG, Marmin BP, Simmons AM, Mccartney. Practical Medical Microbiology - 14th Edition (Churchill Livingstone, London). 1996;385-404.
9. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45(4):493-6. [DOI:10.1093/ajcp/45.4_ts.493] [PMID]
10. Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2021, p: 316.
11. Adam RW, Al-Labban HM, Kadhim IN, Aljanaby, AAJ. Synthesis, characterization, and antibacterial activity of some new pyrimidine derivatives from chalcone derivatives. Drug Invention Today. 2019;11(7):1732-1739.
12. Tamocha L, Oyinloye M, Rahube TO. Airborne bacterial diversity and antibiotic resistance patterns in operating theatre and paediatric wards in Botswana hospitals. African Journal of Microbiology Research. 2019;13(21):341-352. [DOI:10.5897/AJMR2019.9128]
13. El-Kazzaz SS, Mashaly GE, El-Sabbagh AM, Abd Elmagid DS. Resistance genes to sulphonamide in commensal Escherichia coli isolated from stool of patients in Mansoura University Children Hospital. African Journal of Microbiology Research. 2016;10(33):1363-1370. [DOI:10.5897/AJMR2016.8087]
14. Kocúreková T, Karahutová L, Bujňáková D. Antimicrobial Susceptibility and Detection of Virulence-Associated Genes in Escherichia coli Strains Isolated from Commercial Broilers. Antibiotics. 2021;10(11):1303. [DOI:10.3390/antibiotics10111303] [PMID] [PMCID]
15. Kaczmarek A, Budzynska A, Gospodarek E. Prevalence of genes encoding virulence factors among Escherichia coli with K1 antigen and non-K1 E. coli strains. J Med Microbiol. 2012;61(Pt 10):1360-1365. [DOI:10.1099/jmm.0.044263-0] [PMID]
16. Ghazvini H, Taheri K, Edalati E, Miri A, Sedighi M, Mirkalantari S. Virulence factors and antimicrobial resistance in uropathogenic Escherichia coli strains isolated from cystitis and pyelonephritis. Turk J Med Sci. 2019;49(1):361-367. [DOI:10.3906/sag-1805-100] [PMID] [PMCID]
17. Gutiérrez-Lucas LR, Mendoza-Hernández G, González-Pedrajo B, Eslava-Campos C, Bustos-Martínez J, Sainz-Espuñes T. Identification of the autotransporter Pet toxin in Proteus mirabilis strain isolated from patients with urinary tract infections. Advances in Biological Chemistry. 2012;2(3):283. [DOI:10.4236/abc.2012.23036]
18. Al-Yasseen AK, Alatrash AK. The effect of sodium azide on swimming and swarming phenomenon of Proteus mirabilis. International Journal of ChemTech Research. 2017;10(6):865-872.
19. Abbas HM, Al-Mathkhury HJ. Isolation and identification of bacteria from Iraqi women with recurrent urinary tract infection. Plant Archives. 2020;20(2):1838-1842.
20. Alanazi MQ, Alqahtani FY, Aleanizy FS. An evaluation of E. coli in urinary tract infection in emergency department at KAMC in Riyadh, Saudi Arabia: retrospective study. Ann Clin Microbiol Antimicrob. 2018;17(1):3. [DOI:10.1186/s12941-018-0255-z] [PMID] [PMCID]
21. Tuwaij NS. Molecular Profile of Aminoglycoside, Fluoroquinolone, and Class 1 Integron Genes among Gentamicin-Resistant Escherichia coli in Najaf City, Iraq. International Journal of Research in Pharmaceutical Sciences. 2020;11(2):2558-2567. [DOI:10.26452/ijrps.v11i2.2259]
22. Bunduki GK, Heinz E, Phiri VS, Noah P, Feasey N, Musaya J. Virulence factors and antimicrobial resistance of uropathogenic Escherichia coli (UPEC) isolated from urinary tract infections: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):753. [DOI:10.1186/s12879-021-06435-7] [PMID] [PMCID]
23. Alsamarai AM, Khorshed SA, Ali H. Urinary tract infection in female in Kirkuk city, Iraq: Association between risk factors and bacterial type. Our Dermatology Online. 2017;8(3):242. [DOI:10.7241/ourd.20173.72]
24. Yun KW, Kim HY, Park HK, Kim W, Lim IS. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children. Journal of Microbiology, Immunology and Infection. 2014;47(6):455-461. [DOI:10.1016/j.jmii.2013.07.010] [PMID]
25. Rezaei S, Hadadian S, Khavari-Nejad RA, Norouzian D. Recombinant tandem repeated expression of s3 and sδ3 antimicrobial peptides. Rep Biochem Mol Biol. 2020;9(3):348-356. [DOI:10.29252/rbmb.9.3.348] [PMID] [PMCID]
26. Aabed K, Moubayed N, Alzahrani S. Antimicrobial resistance patterns among different Escherichia coli isolates in the Kingdom of Saudi Arabia. Saudi journal of biological sciences. 2021;28(7):3776-3782. [DOI:10.1016/j.sjbs.2021.03.047] [PMID] [PMCID]
27. Rafalskiy V, Pushkar D, Yakovlev S, Epstein O, Putilovskiy M, et al. Distribution and antibiotic resistance profile of key Gram-negative bacteria that cause community-onset urinary tract infections in the Russian Federation: RESOURCE multicentre surveillance 2017 study. J Glob Antimicrob Resist. 2020;21:188-194. [DOI:10.1016/j.jgar.2019.09.008] [PMID]
28. Gutiérrez‐Huante M, Martínez H, Bustamante VH, Puente JL, Sánchez J. Bicarbonate enhances the in vitro antibiotic activity of kanamycin in Escherichia coli. Lett Appl Microbiol. 2015;60(5):440-6. [DOI:10.1111/lam.12388] [PMID]
29. Dobay O, Laub K, Stercz B, Kéri A, Balázs B, Tóthpál A, at al. Bicarbonate inhibits bacterial growth and biofilm formation of prevalent cystic fibrosis pathogens. Front Microbiol. 2018;9:2245. [DOI:10.3389/fmicb.2018.02245] [PMID] [PMCID]
30. Abbassi MS, Kilani H, Abid I, Sáenz Y, Hynds P, Lengliz S, et al. Genetic Background of Antimicrobial Resistance in Multiantimicrobial-Resistant Escherichia coli Isolates from Feces of Healthy Broiler Chickens in Tunisia. Biomed Res Int. 2021:1269849. [DOI:10.1155/2021/1269849] [PMID] [PMCID]
31. Tabidehchi SD, Amini K. Detection of sul1, sul2, and int1 Genes in the Uropathogenic Escherichia coli Strains by Multiplex-PCR and their Antibiotic Susceptibility Patterns. Sadra Medical Journal. 2016;4(3):195-204.
32. Terlizzi ME, Gribaudo G, Maffei ME. UroPathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol. 2017;8:1566. [DOI:10.3389/fmicb.2017.01566] [PMID] [PMCID]
33. Handrová L, Čuvalová A, Kmeť V. The relationship between biofilm formation, genes of virulence and iron metabolism in Escherichia coli. Annales Universitatis Paedagogicae Cracoviensis Studia Naturae. 2018;24-32. [DOI:10.24917/25438832.3supp.3]
34. Espinosa-Antúnez VK, Castrillón-Rivera LE, Vega-Memije ME, Valenzuela-Vargas MT, Sainz-Espuñes T, Luna-Herrera J, et al. Proteus mirabilis expressing Plasmid-encoded toxin (Pet) causes urinary tract alterations. TIP. Revista especializada en ciencias químico-biológicas. 2019;22:1-10. [DOI:10.22201/fesz.23958723e.2019.0.172]
35. Himpsl SD, Shea AE, Zora J, Stocki JA, Foreman D, Alteri CJ, et al. The oxidative fumarase FumC is a key contributor for E. coli fitness under iron-limitation and during UTI. PLoS pathogens. 2020;16(2):e1008382. [DOI:10.1371/journal.ppat.1008382] [PMID] [PMCID]
36. López-Banda DA, Carrillo-Casas EM, Leyva-Leyva M, Orozco-Hoyuela G, Manjarrez-Hernández ÁH, Arroyo-Escalante S, et al. Identification of virulence factors genes in Escherichia coli isolates from women with urinary tract infection in Mexico. Biomed Res Int. 2014;2014:959206. [DOI:10.1155/2014/959206] [PMID] [PMCID]
37. Mahmoud AT, Ibrahem RA, Salim MT, Gabr A, Halby HM. Prevalence of some virulence factors and genotyping of hospital- acquired uropathogenic Escherichia coli isolates recovered from cancer patients. Journal of Global Antimicrobial Resistance. 2020;23:211-216.Skaar EP. The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS pathogens. 2010;6(8):e1000949. [DOI:10.1016/j.jgar.2020.08.003] [PMID]
38. Hagelueken G, Duthie FG, Florin N, Schubert E, Schiemann O. Expression, purification and spin labelling of the ferrous iron transporter FeoB from Escherichia coli BL21 for EPR studies. Protein Expr Purif. 2015;114:30-6. [DOI:10.1016/j.pep.2015.05.014] [PMID]
39. Rocha AC, Rocha SL, Lima-Rosa CA, Souza GF, Moraes HL, Salle FO, et al. Genes associated with pathogenicity of avian Escherichia coli (APEC) isolated from respiratory cases of poultry. Pesquisa Veterinária Brasileira. 2008;28(3):183-186. [DOI:10.1590/S0100-736X2008000300009]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
